Camp4 Therapeutics Corp (CAMP) stock
CAMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.10+0.10 (+2.50%)
Close on Nov 18, 2026Market cap $257.29MP/E –Yield 0.00%
Camp4 Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Camp4 Therapeutics's free cash flow for the twelve months ending Jun 30, 2026 was -$28.72M. For fiscal 2025 it was -$29.83M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$29.83M | – |
| FY2024 | Dec 31, 2024 | -$46.00M | – |
| FY2023 | Dec 31, 2023 | -$44.83M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$12.82M | – |
| Q1 FY2026 | Mar 31, 2026 | -$10.98M | – |
| Q4 FY2025 | Dec 31, 2025 | $6.29M | – |
| Q3 FY2025 | Sep 30, 2025 | -$11.22M | – |
| Q2 FY2025 | Jun 30, 2025 | -$10.34M | – |
| Q1 FY2025 | Mar 31, 2025 | -$14.57M | – |
| Q4 FY2024 | Dec 31, 2024 | -$11.55M | – |
| Q3 FY2024 | Sep 30, 2024 | -$9.69M | – |
| Q2 FY2024 | Jun 30, 2024 | -$13.60M | – |
| Q1 FY2024 | Mar 31, 2024 | -$11.16M | – |
| Q4 FY2023 | Dec 31, 2023 | -$12.03M | – |
See a number that looks wrong?